ViSalus Can't Decertify Class In $925M Robocall Case
Health supplement maker ViSalus brought up arguments about consent too late for a court to consider unraveling a robocall class that won a jury verdict of up to $925 million, an...To view the full article, register now.
Already a subscriber? Click here to view full article